149281-42-5 Usage
General Description
6-Chloro-N-methoxy-N-methyl-nicotinamide is a chemical compound with the molecular formula C9H10ClN2O2. It is a derivative of nicotinamide and contains a chlorine atom, a methoxy group, and a methyl group attached to the nicotinamide ring. 6-CHLORO-N-METHOXY-N-METHYL-NICOTINAMIDE is used in chemical research and has potential applications in the pharmaceutical industry. It may be used in the synthesis of new drugs or as a starting material for the development of new chemical compounds with biological activity. Additionally, 6-Chloro-N-methoxy-N-methyl-nicotinamide may have properties that make it useful for studying biological processes and mechanisms in the body.
Check Digit Verification of cas no
The CAS Registry Mumber 149281-42-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,2,8 and 1 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 149281-42:
(8*1)+(7*4)+(6*9)+(5*2)+(4*8)+(3*1)+(2*4)+(1*2)=145
145 % 10 = 5
So 149281-42-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H9ClN2O2/c1-11(13-2)8(12)6-3-4-7(9)10-5-6/h3-5H,1-2H3
149281-42-5Relevant articles and documents
Direct synthesis of β-aminoketones from amides via novel sequential nucleophilic substitution/Michael reaction
Gomtsyan, Arthur
, p. 11 - 13 (2000)
(formula presented) The synthesis of β-aminoketones from amides can be achieved in a process consisting of sequential nucleophilic substitution at the carbonyl group by vinylmagnesium bromide followed by Michael reaction after quench of the first reaction
ISOQUINOLINE DERIVATIVES AS MGAT2 INHIBITORS
-
Paragraph 0486; 0487, (2018/02/27)
The compounds of Formula I act as MGAT2 inhibitors and can be useful in preventing, treating or acting as a remedial agent for hyperlipidemia, diabetes mellitus and obesity.
PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
-
Page/Page column 130; 131, (2018/08/04)
Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS. (I)